Trial results show significantly faster time to clinical improvement with Favipiravir, claims Glenmark
NE HEALTH BUREAU NEW DELHI, JULY 22 Glenmark Pharmaceuticals Ltd, a global research-led pharmaceutical company, on Wednesday said Phase 3 clinical trial of antiviral drug Favipiravir in mild to mod…
